Literature DB >> 7512367

Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.

A Hagemeijer1, A Buijs, E Smit, B Janssen, G J Creemers, D Van der Plas, G Grosveld.   

Abstract

Leukemic cells from two patients with Philadelphia-negative chronic myeloid leukemia (CML) were investigated: 1) Cytogenetics showed a normal 46,XY karyotype in both cases, 2) molecular studies revealed rearrangement of the M-BCR region and formation of BCR-ABL fusion mRNA with b2a2 (patient 1) or b3a2 (patient 2) configuration, and 3) fluorescence in situ hybridization (FISH) demonstrated relocation of the 5' BCR sequences from one chromosome 22 to one chromosome 9. The ABL probe hybridized to both chromosomes 9 at band q34, while two other probes which map centromeric and telomeric of BCR on 22q11 hybridized solely with chromosome 22. For the first time, a BCR-ABL rearrangement is shown to take place on 9q34 instead of in the usual location on 22q11. A rearrangement in the latter site is found in all Ph-positive CML and in almost all investigated CML with variant Ph or Ph-negative, BCR-positive cases. The few aberrant chromosomal localizations of BCR-ABL recombinant genes found previously were apparently the result of complex and successive changes. Furthermore in patient 2, both chromosomes 9 showed positive FISH signals with both ABL and BCR probes. Restriction fragment length polymorphism (RFLP) analysis indicated that mitotic recombination had occurred on the long arm of chromosome 9 and that the rearranged chromosome 9 was of paternal origin. The leukemic cells of this patient showed a duplication of the BCR-ABL gene, analogous to duplication of the Ph chromosome in classic CML. In addition they had lost the maternal alleles of the 9q34 chromosomal region.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7512367     DOI: 10.1002/gcc.2870080406

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

Authors:  S Pittaluga; I Wlodarska; K Pulford; E Campo; S W Morris; H Van den Berghe; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene.

Authors:  Hiromichi Matsushita; Atsuko Masukawa; Satoshi Arakawa; Yoshiaki Ogawa; Satomi Asai; Miharu Yabe; Kiyoshi Ando; Hayato Miyachi
Journal:  Int J Hematol       Date:  2009-12-10       Impact factor: 2.490

3.  Location of the BCR/ABL Fusion Genes on Both Chromosomes 9 in Ph Negative Young CML Patients: An Indian Experience.

Authors:  Manisha M Brahmbhatt; Pina J Trivedi; Dharmesh M Patel; Shilin N Shukla; Prabhudas S Patel
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

4.  Insertion of the 3' ABL region into the long arm of chromosome 1 in a Philadelphia chromosome-negative chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Thomas Liehr; Abdulsamad Wafa
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

Review 5.  Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase: long-term implications.

Authors:  Alfonso Quintás-Cardama; Jorgé E Cortes; Hagop M Kantarjian
Journal:  Cancer       Date:  2011-05-19       Impact factor: 6.860

6.  Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene.

Authors:  Fumihiko Monma; Kazuhiro Nishii; Shunji Yamamori; Noboru Hosokai; Takahiro Nakazaki; Felipe Lorenzo; Eiji Usui; Miho Sakakura; Hiroyuki Miyashita; Atsushi Fujieda; Kohshi Ohishi; Naoyuki Katayama; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

7.  Carcinogen-induced loss of heterozygosity at the Aprt locus in somatic cells of the mouse.

Authors:  S W Wijnhoven; P P Van Sloun; H J Kool; G Weeda; R Slater; P H Lohman; A A van Zeeland; H Vrieling
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.

Authors:  Simona Luatti; Carmen Baldazzi; Giulia Marzocchi; Gaia Ameli; Maria Teresa Bochicchio; Simona Soverini; Fausto Castagnetti; Mario Tiribelli; Gabriele Gugliotta; Giovanni Martinelli; Michele Baccarani; Michele Cavo; Gianantonio Rosti; Nicoletta Testoni
Journal:  Oncotarget       Date:  2017-05-02

9.  Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.

Authors:  Alexis Rivas; Verónica Burzio; Eduardo Landerer; Vincenzo Borgna; Sebastian Gatica; Rodolfo Ávila; Constanza López; Claudio Villota; Rodrigo de la Fuente; Javiera Echenique; Luis O Burzio; Jaime Villegas
Journal:  BMC Urol       Date:  2012-12-18       Impact factor: 2.264

10.  FISH mapping of Philadelphia negative BCR/ABL1 positive CML.

Authors:  Anna Virgili; Diana Brazma; Alistair G Reid; Julie Howard-Reeves; Mikel Valgañón; Anastasios Chanalaris; Valeria As De Melo; David Marin; Jane F Apperley; Colin Grace; Ellie P Nacheva
Journal:  Mol Cytogenet       Date:  2008-07-18       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.